Peter Rasmussen
Comptroller/Controller/Auditor presso ASCENDIS PHARMA A/S
Patrimonio netto: 53 540 $ in data 30/04/2024
Posizioni attive di Peter Rasmussen
Società | Posizione | Inizio | Fine |
---|---|---|---|
ASCENDIS PHARMA A/S | Comptroller/Controller/Auditor | 01/03/2014 | - |
Direttore Finanziario/CFO | 01/02/2016 | 01/08/2016 |
Storia della carriera di Peter Rasmussen
Precedenti posizioni note di Peter Rasmussen
Società | Posizione | Inizio | Fine |
---|---|---|---|
AdvanDx, Inc.
AdvanDx, Inc. Medical SpecialtiesHealth Technology AdvanDx, Inc. provides advanced molecular diagnostic products for the prevention, diagnosis and treatment of life-threatening, bacterial infections. Its products include QuickFISH BC Tests, PNA FISH Tests, ASR PNA Probes, starter system, accessories and package inserts. The firm offers diagnostic solutions that include antimicrobial stewardship, blood culture contamination, staphylococcal bacteremia, enterococcal bacteremia, gram-negative bacteremia and candidemia. The company was founded by Henrik Stender and Thais T. Johansen in 2002 and is headquartered in Woburn, MA. | Direttore Finanziario/CFO | 01/06/2008 | 01/08/2012 |
VELOXIS PHARMACEUTICALS A/S | Direttore Finanziario/CFO | 01/01/2007 | 01/01/2008 |
Formazione di Peter Rasmussen
Copenhagen Business School | Graduate Degree |
Statistiche
Distribuzione geografica
Danimarca | 4 |
Stati Uniti | 2 |
Posizioni
Director of Finance/CFO | 3 |
Graduate Degree | 1 |
Comptroller/Controller/Auditor | 1 |
Settori
Health Technology | 4 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
ASCENDIS PHARMA A/S | Health Technology |
Aziende private | 2 |
---|---|
AdvanDx, Inc.
AdvanDx, Inc. Medical SpecialtiesHealth Technology AdvanDx, Inc. provides advanced molecular diagnostic products for the prevention, diagnosis and treatment of life-threatening, bacterial infections. Its products include QuickFISH BC Tests, PNA FISH Tests, ASR PNA Probes, starter system, accessories and package inserts. The firm offers diagnostic solutions that include antimicrobial stewardship, blood culture contamination, staphylococcal bacteremia, enterococcal bacteremia, gram-negative bacteremia and candidemia. The company was founded by Henrik Stender and Thais T. Johansen in 2002 and is headquartered in Woburn, MA. | Health Technology |
Veloxis Pharmaceuticals A/S
Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark. | Health Technology |
- Borsa valori
- Insiders
- Peter Rasmussen
- Esperienza